The January 2019 edition of the British Journal of Psychiatry has, as its theme: Treatment-Resistant Mood Disorders. In the Journal a “consensus definition” of “treatment resistance” was provided by a … Continue reading “A wrong un’ when you see it”
Science is important to us all. This post is an attempt to explore some of the broad issues that we need to consider to ensure scientific integrity. Science is more … Continue reading The Narrative Controllers
This event hosted by the Royal Society of Medicine will take place at 1 Wimpole Street, London on the 29th January 2019. It has been approved for 6 CPD points. … Continue reading “This unique event will bring together world leaders in research on depression”
This is my latest post as part of a series reporting the available information on competing financial interests in ‘key opinion leaders’ in British psychiatry. Professor Guy Goodwin’s declaration of competing … Continue reading Professor Guy Goodwin
This is my latest post as part of a series reporting the available information on competing financial interests in ‘key opinion leaders’ in British psychiatry. This is Professor Anthony Cleare’s … Continue reading Professor Anthony Cleare
I am a celebrant of subjectivity and a seeker of objectivity. I share here [the generally hidden] commercial influences of ‘key opinion leaders’ in British Psychiatry:
The current edition of the British Journal of Psychiatry, May 2018, contains academic papers on depressive disorders. In this post I will share some of the declarations of interest linked … Continue reading The British Journal of Psychiatry: are competing interests of authors sufficiently transparent?